The government will ban compounding pharmacists from making replica versions of diabetes drugs like Ozempic and Mounjaro, widely used off-label for weight loss, amid public safety concerns. The government will ban compounding pharmacists from making replica versions of diabetes drugs like Ozempic and Mounjaro, widely used off-label for weight loss, amid public safety concerns. Obesity, Health, Pharmaceuticals, Pharmaceutical Industry, Health Policy, Government Policy, Diabetes Latest business news
‘We need to shut down this market’: Replica weight loss drugs banned, filthy pharmaceutical lab raided
